Identification of Myths and Misinformation About Treatment for Opioid Use Disorder on Social Media: Infodemiology Study

Overview

Journal JMIR Form Res

Publisher JMIR Publications

Specialty Biomedical Engineering

Date 2024 Feb 23

PMID 38393772

Authors

Mai ElSherief

Steven Sumner

Vikram Krishnasamy

Christopher Jones

Royal Law

Akadia Kacha-Ochana

Lyna Schieber

Munmun De Choudhury

Affiliations

Soon will be listed here.

Abstract

Background: Health misinformation and myths about treatment for opioid use disorder (OUD) are present on social media and contribute to challenges in preventing drug overdose deaths. However, no systematic, quantitative methodology exists to identify what types of misinformation are being shared and discussed.

Objective: We developed a multistage analytic pipeline to assess social media posts from Twitter (subsequently rebranded as X), YouTube, Reddit, and Drugs-Forum for the presence of health misinformation about treatment for OUD.

Methods: Our approach first used document embeddings to identify potential new statements of misinformation from known myths. These statements were grouped into themes using hierarchical agglomerative clustering, and public health experts then reviewed the results for misinformation.

Results: We collected a total of 19,953,599 posts discussing opioid-related content across the aforementioned platforms. Our multistage analytic pipeline identified 7 main clusters or discussion themes. Among a high-yield data set of posts (n=303) for further public health expert review, these included discussion about potential treatments for OUD (90/303, 29.8%), the nature of addiction (68/303, 22.5%), pharmacologic properties of substances (52/303, 16.9%), injection drug use (36/303, 11.9%), pain and opioids (28/303, 9.3%), physical dependence of medications (22/303, 7.2%), and tramadol use (7/303, 2.3%). A public health expert review of the content within each cluster identified the presence of misinformation and myths beyond those used as seed myths to initialize the algorithm.

Conclusions: Identifying and addressing misinformation through appropriate communication strategies could be an increasingly important component of preventing overdose deaths. To further this goal, we developed and tested an approach to aid in the identification of myths and misinformation about OUD from large-scale social media content.

References

ElSherief M, Sumner S, Jones C, Law R, Kacha-Ochana A, Shieber L . Characterizing and Identifying the Prevalence of Web-Based Misinformation Relating to Medication for Opioid Use Disorder: Machine Learning Approach. J Med Internet Res. 2021; 23(12):e30753. PMC: 8734931. DOI: 10.2196/30753. View

Vosoughi S, Roy D, Aral S . The spread of true and false news online. Science. 2018; 359(6380):1146-1151. DOI: 10.1126/science.aap9559. View

Sarker A, Gonzalez-Hernandez G, Ruan Y, Perrone J . Machine Learning and Natural Language Processing for Geolocation-Centric Monitoring and Characterization of Opioid-Related Social Media Chatter. JAMA Netw Open. 2019; 2(11):e1914672. PMC: 6865282. DOI: 10.1001/jamanetworkopen.2019.14672. View

Young S, Koussa M, Lee S, Perez H, Gill N, Gelberg L . Feasibility of a social media/online community support group intervention among chronic pain patients on opioid therapy. J Addict Dis. 2019; 37(1-2):96-101. PMC: 6551263. DOI: 10.1080/10550887.2018.1557992. View

Chenworth M, Perrone J, Love J, Graves R, Hogg-Bremer W, Sarker A . Methadone and suboxone mentions on twitter: thematic and sentiment analysis. Clin Toxicol (Phila). 2021; 59(11):982-991. PMC: 9177078. DOI: 10.1080/15563650.2021.1893742. View

Luo F, Li M, Florence C . State-Level Economic Costs of Opioid Use Disorder and Fatal Opioid Overdose - United States, 2017. MMWR Morb Mortal Wkly Rep. 2021; 70(15):541-546. PMC: 8344997. DOI: 10.15585/mmwr.mm7015a1. View

Yang L, Grivel M, Anderson B, Bailey G, Opler M, Wong L . A new brief opioid stigma scale to assess perceived public attitudes and internalized stigma: Evidence for construct validity. J Subst Abuse Treat. 2019; 99:44-51. PMC: 6716158. DOI: 10.1016/j.jsat.2019.01.005. View

Wardhan R, Chelly J . Recent advances in acute pain management: understanding the mechanisms of acute pain, the prescription of opioids, and the role of multimodal pain therapy. F1000Res. 2017; 6:2065. PMC: 5710326. DOI: 10.12688/f1000research.12286.1. View

Breza E, Stanford F, Alsan M, Alsan B, Banerjee A, Chandrasekhar A . Effects of a large-scale social media advertising campaign on holiday travel and COVID-19 infections: a cluster randomized controlled trial. Nat Med. 2021; 27(9):1622-1628. PMC: 8440209. DOI: 10.1038/s41591-021-01487-3. View

10.

van Boekel L, Brouwers E, van Weeghel J, Garretsen H . Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013; 131(1-2):23-35. DOI: 10.1016/j.drugalcdep.2013.02.018. View

11.

Pennycook G, McPhetres J, Zhang Y, Lu J, Rand D . Fighting COVID-19 Misinformation on Social Media: Experimental Evidence for a Scalable Accuracy-Nudge Intervention. Psychol Sci. 2020; 31(7):770-780. PMC: 7366427. DOI: 10.1177/0956797620939054. View

12.

Hedegaard H, Minino A, Spencer M, Warner M . Drug Overdose Deaths in the United States, 1999-2020. NCHS Data Brief. 2022; (426):1-8. View

13.

Hochreiter S, Schmidhuber J . Long short-term memory. Neural Comput. 1997; 9(8):1735-80. DOI: 10.1162/neco.1997.9.8.1735. View

14.

Barber M, Gardner J, Savic M, Carter A . Ibogaine therapy for addiction: Consumer views from online fora. Int J Drug Policy. 2020; 83:102857. DOI: 10.1016/j.drugpo.2020.102857. View

15.

Kennedy-Hendricks A, Busch S, McGinty E, Bachhuber M, Niederdeppe J, Gollust S . Primary care physicians' perspectives on the prescription opioid epidemic. Drug Alcohol Depend. 2016; 165:61-70. PMC: 4939126. DOI: 10.1016/j.drugalcdep.2016.05.010. View

16.

Suarez-Lledo V, Alvarez-Galvez J . Prevalence of Health Misinformation on Social Media: Systematic Review. J Med Internet Res. 2021; 23(1):e17187. PMC: 7857950. DOI: 10.2196/17187. View

17.

Volkow N, Frieden T, Hyde P, Cha S . Medication-assisted therapies--tackling the opioid-overdose epidemic. N Engl J Med. 2014; 370(22):2063-6. DOI: 10.1056/NEJMp1402780. View

18.

Tibebu S, Chang V, Drouin C, Thompson W, Do M . At-a-glance - What can social media tell us about the opioid crisis in Canada?. Health Promot Chronic Dis Prev Can. 2018; 38(6):263-267. PMC: 6034970. DOI: 10.24095/hpcdp.38.6.08. View

19.

Madras B, Ahmad N, Wen J, Sharfstein J . Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System. NAM Perspect. 2022; 2020. PMC: 8916813. DOI: 10.31478/202004b. View

20.

Heimer R, Hawk K, Vermund S . Prevalent Misconceptions About Opioid Use Disorders in the United States Produce Failed Policy and Public Health Responses. Clin Infect Dis. 2018; 69(3):546-551. PMC: 6637277. DOI: 10.1093/cid/ciy977. View